The stereotypical medicated kid in America is wealthy and spoiled and retains a psychiatrist to guarantee him extra time on tests or to help process the emotional fallout of being neglected by high-powered working parents. In this formulation, rich kids have psychological problems, and poor kids have real problems. But the stereotype isn't accurate; the correlation is, in fact, the opposite. Children in poor families are significantly more likely to be diagnosed with emotional and behavioral problems and to be prescribed medication. Our national understanding of youth and mental health starts with an important mistake.
This new ADHD medication for kids comes in a fruity package.
Adzenys XR-ODT, an extended-release amphetamine, was released in May and is aimed at children 6 years and older with attention-deficit hyperactivity disorder. More than 11 percent of kids ages 4 to 17 have ADHD, and 75 percent of those children take medication, the CDC reports.
Antipsychotic prescribing rates for children in foster care and for other Medicaid-insured children have leveled off following a period of rapid growth in the early and mid 2000s. However, guideline-recommended practices are frequently still not followed, new research shows.
A new Finnish study shows that fetal exposure to commonly used SRI drugs may affect brain activity in newborns. The researchers suggest that the effects of drugs on fetal brain function should be assessed more carefully. Furthermore, indications for preventive medication should be critically evaluated, and non-pharmacological interventions should be the first-line treatment for depression and anxiety during pregnancy.
When I was in elementary school, my two best friends were diagnosed with depression and given psychiatric drugs. They were both eight years old. At the time, I was weirdly jealous; I felt like they got more treats than me and the teachers gave them special attention. At one stage, I even made my mom take me to the doctor's, just to check that I wasn't depressed too.